Olivo Alicia C — SEC Form 4 filings
SEC reporting owner CIK 1951869. 24 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-02-20 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 35,685 shares, $451,567 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 20,916 shares @ $12.00 ($250,992) in NEOGENOMICS INC, filed 2025-11-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEOGENOMICS INC (NEO) | EVP, GC & Business Development | 24 | — | 6 legs · 35,685 sh · $451,567 | 42 |
Form 4 filings — Olivo Alicia C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 2,692 @ $0 | EDGAR |
| 2026-05-13 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 3,944 @ $0 · Tax withholding (F): 2,559 @ $0 · Option exercise (M): 3,944 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 1,042 @ $0 | EDGAR |
| 2026-03-03 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 147,804 (derivative) @ $0 · Grant/award (A): 89,013 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 21,079 @ $0 · Tax withholding (F): 8,295 @ $0 · Option exercise (M): 8,443 @ $0 · Tax withholding (F): 3,323 @ $0 · Option exercise (M): 21,079 (derivative) @ $0 · Option exercise (M): 8,443 (derivative) @ $0 | EDGAR |
| 2026-01-15 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 59,382 @ $0 · Tax withholding (F): 15,145 @ $0 | EDGAR |
| 2025-11-28 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 8,977 @ $10.05 · Sale (S): 20,916 @ $12 · Option exercise (M): 8,977 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | NEOGENOMICS INC (NEO) | Sale (S): 4,918 @ $10 | EDGAR |
| 2025-09-03 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 1,666 @ $0 | EDGAR |
| 2025-08-05 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 14 @ $0 | EDGAR |
| 2025-05-13 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 6,503 @ $0 · Tax withholding (F): 1,584 @ $0 · Option exercise (M): 6,503 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 652 @ $0 | EDGAR |
| 2025-02-25 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 8,443 @ $0 · Tax withholding (F): 2,504 @ $0 · Grant/award (A): 107,450 (derivative) @ $0 · Grant/award (A): 63,238 (derivative) @ $0 · Option exercise (M): 8,443 (derivative) @ $0 | EDGAR |
| 2025-01-16 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 59,382 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4/A | NEOGENOMICS INC (NEO) | Option exercise (M): 6,502 @ $0 · Tax withholding (F): 1,584 @ $14.86 · Option exercise (M): 6,502 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | NEOGENOMICS INC (NEO) | Sale (S): 5,175 @ $15.36 | EDGAR |
| 2024-09-04 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 1,666 @ $0 | EDGAR |
| 2024-08-19 | 4 | NEOGENOMICS INC (NEO) | Sale (S): 1,040 @ $16.05 | EDGAR |
| 2024-08-05 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 14 @ $0 | EDGAR |
| 2024-05-17 | 4 | NEOGENOMICS INC (NEO) | Sale (S): 1,049 @ $15.74 | EDGAR |
| 2024-05-14 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 6,502 @ $0 · Tax withholding (F): 1,584 @ $14.86 · Option exercise (M): 6,502 @ $0 · Option exercise (M): 6,502 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 652 @ $0 | EDGAR |
| 2024-02-27 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 42,344 (derivative) @ $0 · Grant/award (A): 25,329 (derivative) @ $0 · Grant/award (A): 25,330 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | NEOGENOMICS INC (NEO) | Sale (S): 2,587 @ $14.96 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1951869 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →